Correlation Between Medicenna Therapeutics and NervGen Pharma
Can any of the company-specific risk be diversified away by investing in both Medicenna Therapeutics and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicenna Therapeutics and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicenna Therapeutics Corp and NervGen Pharma Corp, you can compare the effects of market volatilities on Medicenna Therapeutics and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicenna Therapeutics with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicenna Therapeutics and NervGen Pharma.
Diversification Opportunities for Medicenna Therapeutics and NervGen Pharma
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Medicenna and NervGen is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Medicenna Therapeutics Corp and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and Medicenna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicenna Therapeutics Corp are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of Medicenna Therapeutics i.e., Medicenna Therapeutics and NervGen Pharma go up and down completely randomly.
Pair Corralation between Medicenna Therapeutics and NervGen Pharma
Assuming the 90 days trading horizon Medicenna Therapeutics Corp is expected to under-perform the NervGen Pharma. In addition to that, Medicenna Therapeutics is 1.07 times more volatile than NervGen Pharma Corp. It trades about -0.18 of its total potential returns per unit of risk. NervGen Pharma Corp is currently generating about 0.14 per unit of volatility. If you would invest 177.00 in NervGen Pharma Corp on September 5, 2024 and sell it today you would earn a total of 28.00 from holding NervGen Pharma Corp or generate 15.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 91.3% |
| Values | Daily Returns |
Medicenna Therapeutics Corp vs. NervGen Pharma Corp
Performance |
| Timeline |
| Medicenna Therapeutics |
| NervGen Pharma Corp |
Medicenna Therapeutics and NervGen Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Medicenna Therapeutics and NervGen Pharma
The main advantage of trading using opposite Medicenna Therapeutics and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicenna Therapeutics position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.| Medicenna Therapeutics vs. Royal Bank of | Medicenna Therapeutics vs. Toronto Dominion Bank Pref | Medicenna Therapeutics vs. Toronto Dominion Bank | Medicenna Therapeutics vs. Amazon CDR |
| NervGen Pharma vs. Vg Life Sciences | NervGen Pharma vs. Adagene | NervGen Pharma vs. Marizyme | NervGen Pharma vs. Mymetics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |